News
ENZ
1.340
-2.90%
-0.040
Weekly Report: what happened at ENZ last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at ENZ last week (0212-0216)?
Weekly Report · 02/19 09:31
Weekly Report: what happened at ENZ last week (0205-0209)?
Weekly Report · 02/12 09:28
Weekly Report: what happened at ENZ last week (0129-0202)?
Weekly Report · 02/05 09:31
Enzo Biochem Announces 2023 Annual Meeting Outcomes
TipRanks · 02/02 09:20
Enzo Biochem Shareholders Elect Directors, Reject Exec Pay
TipRanks · 02/02 09:20
Enzo Biochem Appoints New CEO and CFO
TipRanks · 02/02 09:19
Laughing Water Capital Q4 2023 Letter
For Q4 2023, Class A interests in Laughing Water Capital returned approximately 3.2%. The SP500TR and R2000 returned 11.7% and 14.0% for the quarter. Since inception, LWC has returned approximately 245% in 2023.
Seeking Alpha · 02/01 08:21
Weekly Report: what happened at ENZ last week (0122-0126)?
Weekly Report · 01/29 09:28
Weekly Report: what happened at ENZ last week (0115-0119)?
Weekly Report · 01/22 09:29
Weekly Report: what happened at ENZ last week (0108-0112)?
Weekly Report · 01/15 09:28
Weekly Report: what happened at ENZ last week (0101-0105)?
Weekly Report · 01/08 09:29
Weekly Report: what happened at ENZ last week (1225-1229)?
Weekly Report · 01/01 09:28
Weekly Report: what happened at ENZ last week (1218-1222)?
Weekly Report · 12/25/2023 09:31
Weekly Report: what happened at ENZ last week (1211-1215)?
Weekly Report · 12/18/2023 09:32
HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday
Wall Street expects HEICO Corporation to report quarterly earnings at 68 cents per share on revenue of $898.25 million after the closing bell. Analysts expect GEE Group Inc. To release earnings after the markets close. Enzo Biochem, Inc. Posted a loss of 13 cents for the first quarter.
Benzinga · 12/18/2023 07:46
ENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024
Enzo Biochem just reported results for the first quarter of 2024. The company reported earnings per share of -11 cents and revenue of $7.81 million. InvestorPlace Earnings is a project that automates coverage of quarterly earnings reports to help readers understand the figures.
Investorplace · 12/16/2023 03:51
More
Webull provides a variety of real-time ENZ stock news. You can receive the latest news about Enzo Biochem Inc through multiple platforms. This information may help you make smarter investment decisions.
About ENZ
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.